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Abstract. The clinical epidemiology of severe malaria among patients presenting to peripheral health centers has not
been well described. We conducted a prospective, observational cohort study to describe the epidemiology and clinical
manifestations of severe malaria in a highland area of declining transmission intensity in Western Uganda. Individuals
presentingwith a history of feverwere screenedwith amalaria rapid diagnostic test (RDT).Wepreparedblood smears and
conducted clinical and laboratory testing for those with a positive RDT. We defined severe malaria in accordance with
World Health Organization guidelines for research and epidemiological studies. A total of 6,641 individuals underwent
testing for malaria. Ninety-six of 1,462 (6.6%) participants with confirmed parasitemia satisfied the criteria for severe
malaria. The incidence of severe malaria peaked between 2 and 3 years of age (incidence rate ratio = 17.1, 95%
confidence interval = 8.4–34.9, P < 0.001) and then declined steadily until age 10. However, we also found a second peak
among those ³ 50 years of age. Severe anemia was uncommon, detected in only 5.3% of cases. Instead, shock (22.2%)
and lactic acidosis (19.4%) were most frequently encountered. Our results suggest that the clinical characteristics of
severemalaria presenting to rural, peripheral health centers may be different than previously observed in referral centers.
These findingsmerit further investigation into the optimalmethods for identification andmanagement of severemalaria in
rural health centers in the region.
INTRODUCTION
After more than a decade of investments in control pro-
grams, significant progress has been made in reducing the
global burden of malaria.1 Yet, severe Plasmodium falciparum
malaria remains a leading cause of pediatric morbidity and
mortality in sub-SaharanAfrica, accounting for nearly 300,000
deaths among children less than 5 years of age.2 Although
much of the gains were achieved by reducing malaria trans-
mission, there have been relatively few advances in the di-
agnosis and clinical management of severe malaria, a
situation that some consider to be a neglected strategic
priority.3
Traditionally, severe malaria has been diagnosed based on
the presence of one of three distinct clinical syndromes: se-
vere anemia, cerebral malaria, or respiratory distress. The
prevalence of these syndromes among children with severe
malaria, however, varies with transmission intensity. Severe
anemia is generally more common in areas of high trans-
mission, whereas cerebral malaria is more common in areas
with low or seasonal transmission.4–7 In a high-transmission
area of Uganda, for example, a recent study found that 65%
of children with severe malaria admitted to a large academic
referral center had severe anemia, whereas only 20% had
cerebral malaria.8
Most of the landmark studies describing these syndromes
were conducted at district hospitals and referral centers. Yet in
Uganda, nearly one-third of children with acute febrile illness
who seek care do so at public health centers.9 These facilities
are not staffed by physicians and typically lack the requisite
laboratory infrastructure to establish a diagnosis of severe
malaria.10 Although most guidelines recommend referral for
patients with severe malaria, the financial and logistic re-
sources required may limit this practice.11,12 Therefore, a
better understanding of the epidemiology and clinical mani-
festations of severe malaria in peripheral health centers is of
critical importance to developing appropriate diagnostic al-
gorithms and treatment protocols for these resource-limited
settings.
We conducted a prospective cohort study in rural Uganda
among individuals presenting to a rural health-care facility
with undifferentiated fever. The objectives of the study were
to describe the demographic, clinical, and laboratory char-
acteristics of severe malaria at a peripheral health center in a
high-transmission setting. As a secondary objective, we
sought to examine the burden of severe malaria in adults,
which is less well studied but could become increasingly
important as malaria transmission and acquired immunity
decline, and as life expectancy increases in many endemic
countries.
MATERIALS AND METHODS
Study setting. The Bugoye Level III Health Center (BHC) in
the Kasese District of Western Uganda (0189 N, 3059 E)
functions as the primary health center for the Bugoye sub-
county. This rural sub-county comprises 36 villages and
covers an area of approximately 55 km2. The catchment area
of the health center includesmore than 50,000 residents of the
Bugoye sub-county as well as residents of neighboring vil-
lages from theMaliba sub-county immediately to theEast. The
health centermaintainsgeneral, pediatric, andobstetricwards
for inpatient services, along with a busy outpatient depart-
ment (OPD) that cares for 60–80patientsperday.Clinical officers,
nurses, midwives, and laboratory technicians employed by
the Ugandan Ministry of Health staff the health center. During
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evening hours and on weekends when the OPD is closed,
patients are referred directly for review at the inpatient ward.
Patients requiring a higher level of care are usually referred to
Kilembe Mines Hospital, a district hospital, which is located
approximately 25 km from BHC via a mix of dirt and paved
roads. Transport, often by motorcycle, typically takes 45
minutes at costs that can represent the weekly income for a
typical subsistence farmer.13
Like much of Uganda, the climate in Bugoye permits year-
round malaria transmission marked by semiannual trans-
mission peaks typically after the end of the rainy seasons.14
The two most recent malaria indicator surveys undertaken in
the region found declining parasitemia prevalence of 48.4%
and 17.6% in 2009 and 2014, respectively.9,15
Study design. The rapid diagnostic test (RDT) for severe
malaria study was a prospective, observational cohort study
of patients with a parasitological diagnosis of malaria con-
ducted from May to November 2015. Study staff recorded
demographic information, clinical history, and vital signs to
include temperature, blood pressure, heart rate, respiratory
rate, and oxygen saturation on all individuals presenting to the
OPD using a study-specific encounter form. Health facility
staff, typically nurses and clinical officers, then performed
clinical evaluations of all patients in accordance with local
protocols, recording diagnostic and treatment plans on the
same encounter form. Individuals with fever (axillary temper-
ature ³ 38C) or other symptoms suspicious for malaria as
determined by the attendant provider were eligible for
inclusion.
Initial testing for malaria was performed using the Standard
Diagnostics 05FK60 Malaria Ag P. falciparum/Pan RDT assay
(StandardDiagnostics,Hagal-Dong,Korea). StudyRDTswere
obtained directly from the manufacturer, stored in the original
packaging at room temperature, and used in accordance with
the manufacturer’s instructions before the expiry date.
Study staff with training in laboratory medicine prepared
thin and thick blood smears for all patients with a positive RDT
result. Those with a negative RDT were defined as not having
severe malaria and did not undergo further testing, except for
the 15% of individuals who underwent microscopy for quality
control. Smears were fixed with methanol and stained in 10%
Giemsa.Microscopists, whohadundergone validation testing
(Shoklo Malaria Research Unit) and were blinded to the RDT
results, reviewed all slides in accordance with World Health
Organization (WHO) guidelines.16 Two independent micros-
copists read all slides. A third, senior microscopist reviewed
the slides when there were discrepancies between the first
two reads. Dried blood spots were obtained from a subset of
participants over a 1-month period and real-time polymerase
TABLE 1
Study criteria for severe malaria required Plasmodium falciparum
parasitemia on microscopy and/or polymerase chain reaction and
any one of the following
Impaired consciousness Blantyrecomascore<3 for childrenunder
5 years of age or Glasgow coma score
< 11 for adults
Metabolic acidosis Plasma bicarbonate of < 15 mmol/L or
venous plasma lactate > 5 mmol/L
Hypoglycemia Blood or plasma glucose < 40 mg/dL
(< 2.2 mmol/L)
Severe anemia A hemoglobin concentration < 5 g/dL in
children < 12 years and < 7 g/dL in
adults together with a parasite count
> 10,000/μL
Kidney injury Plasma or serum creatinine > 3 mg/dL &
blood urea nitrogen ³ 20 mg/dL
Pulmonary edema Oxygensaturation < 92%on roomairwith
a respiratory rate > 30/minutes
Shock Systolic blood pressure < 70 mm Hg
Convulsions History of seizures during present illness
Hyperparasitemia P. falciparum parasitemia > 250,000/μL
FIGURE 1. Cumulative proportion of severe malaria cases showing that nearly 90% of cases observed before the age of 15 years. This figure
appears in color at www.ajtmh.org.
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chain reaction (PCR)was performed to assess the accuracy of
microscopy, details of which are published elsewhere.17
Hemoglobin levels were measured using the Hemocue
Hb 201+ analyzer (Hemocue, Brea, CA), whereas serum
chemistry and venous blood gas values were obtained using
the Abbott iStat analyzer (Abbott, Princeton, NJ) with the
CHEM8+ and CG4+ cartridges.
After diagnostic testing was complete, point-of-care re-
sults were provided to the responsible provider for clinical
management purposes. Patients with diagnostic tests pos-
itive formalariawere treated at the discretion of the attendant
provider which is typically patterned according to national
guidelines.18 Available treatment options usually include oral
artemether/lumefantrine for uncomplicated malaria or par-
enteral quinine or artesunate for severemalaria. We recorded
treatment and disposition plans, including admission to the
inpatient ward and referral to higher level facilities. In-
formation on mortality was retrospectively abstracted from
the inpatient registers.
Statistical analysis. We defined severe malaria in accor-
dance with the WHO guidelines for research and epidemio-
logical studies.19,20 These criteria are outlined in Table 1.
Notably, these criteria are less dependent on clinical assess-
ments, such as the presence of acidotic breathing, the de-
termination of which can vary significantly with the level of
health worker training and clinical skill.10,21,22 For this study,
we defined hyperparasitemia as a threshold of ³ 250,000
parasites/μL.
We first summarized demographic, clinical, and laboratory
characteristics of the cohort and compared them between
those with uncomplicated and severe malaria using linear re-
gression for continuous variables and Pearson’s χ2 testing
and/or logistic regression for categorical variables. We strat-
ified results by age, with three primary categories: age < 5,
5–15, and ³ 15 years. Parasite densities were log-transformed
and reported as geometric means.
We determined the age-specific incidence rate ratio (IRR)
of severe malaria among individuals with microscopically
confirmed parasitemia using generalized negative binomial
regression models with robust standard errors. We first ex-
amined differences between the above-described age cat-
egories, and then performed an exploratory analysis among
children < 15 years by treating age as a continuous variable.
We also compared the IRR of severe malaria between those
15–49 years old and older patients, defined as those ³ 50
years of age. Using similar methods, we determined the
village-level IRR for all villages with at least three cases of
severe malaria over the study period, defining Bugoye vil-
lage, where the health center is located as the reference
village.
TABLE 2
Laboratory results of patients meeting the criteria for severe Plasmodium falciparummalaria stratified by age
Characteristic
Age < 5 Age 5–15 Age ³ 15
P value† P value‡Uncomplicated Severe P* Uncomplicated Severe P* Uncomplicated Severe P*
Patients (n, %) 142 (79.3) 37 (20.7) – 687 (93.5) 48 (6.5) – 528 (98.0) 11 (2.0) – – –
Female (n, %) 64 (45.1) 17 (46.0) 0.92 337 (49.7) 20 (41.7) 0.28 316 (60.8) 8 (72.7) 0.42 0.074 0.13
Onset (median, IQR) 2 (1–3) 2 (1–3) 0.39 2 (2–3) 3 (2–3) 0.93 3 (2–4) 2 (2–3) 0.67 0.77 0.23
Symptoms (n, %)
Fever 136 (97.2) 38 (97.3) 0.97 636 (92.6) 44 (91.7) 0.82 482 (91.3) 11 (100.0) 0.31 0.30 1.0
Cough 81 (57.0) 19 (51.4) 0.54 255 (37.1) 19 (39.6) 0.73 166 (31.4) 2 (18.2) 0.35 0.20 0.07
Rhinorrhea 41 (28.9) 6 (16.2) 0.12 130 (18.9) 10 (20.8) 0.75 76 (14.4) 1 (9.1) 0.62 0.38 0.56
Diarrhea 27 (19.0) 9 (24.3) 0.47 71 (10.3) 6 (12.5) 0.64 30 (5.7) 4 (36.4) < 0.001 0.07 0.43
Convulsion – 8 (21.6) – – 3 (6.3) – – 0 (0.0) – – 0.048§
Vital signs (n, %)
MUAC (cm) 17.1 14.6 0.77 – – – – – – – –
Coma scalek 4.96 4.73 0.001 15.0 14.9 0.14 15.0 13.8 < 0.001 0.006 –
Febrile 46 (33.6) 21 (56.8) 0.01 182 (27.4) 17 (37.0) 0.16 71 (14.3) 1 (10.0) 0.70 0.13 0.025
Tachpynea 6 (4.7) 5 (15.2) 0.034 82 (12.5) 6 (13.3) 0.87 86 (17.2) 7 (70.0) < 0.001 0.001 0.002
Tachycardic 37 (27.6) 13 (40.6) 0.15 248 (36.3) 18 (40.0) 0.62 141 (27.0) 7 (63.6) 0.007 0.17 0.19
Shock – 6 (18.2) – – 12 (26.1) – – 2 (18.2) – 0.59 1.0
Pulmonary edema – 9 (27.3) – – 5 (11.1) – – 1 (10.0) – 0.92 0.28
Microscopy results
GMPD 7,016/μL 38,139/μL < 0.001 8,453/μL 31,253/μL < 0.001 3,292/μL 12,211/μL 0.03 0.14 0.08
> 100,000 (n, %) 20 (14.1) 16 (43.2) < 0.001 45 (6.6) 16 (33.3) < 0.001 12 (2.3) 2 (18.2) 0.001 0.33 0.15
Hyperparasitemia – 9 (24.3) – – 10 (20.8) – – 0 (0.0) – – 0.70§
Anemia
Hb (Mean, 95% CI) 10.1 g/dL 9.9 g/dL 0.61 11.7 g/dL 11.5 g/dL 0.43 13.4 g/dL 12.5 g/dL 0.14 0.17 0.003
Hb < 5 g/dL (n, %) 2 (1.6) 1 (3.0) 0.59 – 2 (4.2) – – 0 (0.0) – – 0.79
Hypoglycemia (n, %) – 0 (0.0) – – 3 (6.4) – – 3 (30.0) – 0.04 –
Kidney injury (n, %) – 0 (0.0) – – 0 (0.0) – – 3 (27.3) – – –
Acidosis (n, %)
Lactate (mean) 2.08 2.83 0.001 1.93 3.44 < 0.001 1.67 3.36 < 0.001 0.89 0.42
> 5 mmol/L – 4 (14.3) – – 12 (25.5) – – 3 (27.3) – 0.91 0.35
HCO3 (,ean) 21.3 19.0 < 0.001 23.7 21.8 < 0.001 25.0 21.6 < 0.001 0.92 0.04
HCO3 < 15 mmol/L – 5 (17.9) – – 3 (6.4) – – 1 (9.1) – 0.75 0.50
CI= confidence interval; GMPD=geometricmeanparasite density;Hb=hemoglobin;HCO3= serumbicarbonate; IQR= interquartile range;MUAC=mid-upper armcircumference. Values in bold
represent measures that define the criteria for severe malaria.
*P value for comparison of uncomplicated vs. severe malaria within the respective age category.
†P value for comparison between age categories 5–15 years and ³ 15 years of age (reference) with severe malaria.
‡P value for comparison between age categories < 5 years and ³ 15 years of age (reference) with severe malaria.
§No observations in the reference group; comparison made between age categories 5–15 years and < 5 years.
kGlasgow Coma Score used for patients ³ 5 years of age; Blantyre Coma Score used for patients < 5 years of age.
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Finally, we performed multivariable regression analyses
using generalized negative binomial regression models with
robust standard errors to explore the demographic, clinical,
and laboratory parameters associated with the primary out-
come of interest, severe malaria, in each age group. Cova-
riates that would routinely be available at a peripheral health
center (e.g., demographics, physical examination findings,
and microscopy results) were included in the multivariable
model, regardless of the level of significance in the univariable
modeling. A resulting P value of < 0.05 was considered sta-
tistically significant in the final models. Data were analyzed
with Stata 12.1 (Stata Corp., College Station, TX).
Ethics statement. Ethical approval of the study was pro-
vided by the institutional review boards of Partners Health-
care, the University of North Carolina at Chapel Hill, the
Mbarara University of Science and Technology, and the
UgandaNational Council for Science andTechnology.Written
informed consent was obtained from all adult study partici-
pants and the caregivers of participating children.
RESULTS
During the 6-month study period, a total of 6,681 individuals
presented with a history and/or symptoms suspicious for
malaria and underwent testing with an RDT. Characteristics of
the study cohort are shown in Supplemental Table 1. RDT
results were available for 99.4% (6,641/6,681) of individuals.
Nearly 40% (2,562/6,641) of those tested had a positive RDT
result and of these, approximately 80% (2,085/2,562) con-
sented to participate in the study protocol. Microscopic ex-
amination confirmed thepresenceofP. falciparumparasitemia
in 1,462 (70.1%) of individuals with a positive RDT, either as an
isolated infection (1,440, 98.5%) or in combination with an-
other Plasmodium species (22, 1.5%). Among the subset of
samples that underwent parallel real-time PCR (N = 267) for
quality control, slide reading demonstrated a high degree of
agreement (κ = 0.85).17 Individuals with microscopically con-
firmed parasitemia were subsequently included in the sub-
sequent analyses.
Ninety-six of 1,462 (6.6%) participants with confirmed para-
sitemia satisfied the criteria for severe P. falciparum malaria
(Supplemental Table 2). Nearly half of severe cases occurred in
children < 5 years of age and almost 90% of cases were di-
agnosed among children < 15 years of age (Figure 1). The
proportion of individuals with severe as compared with un-
complicated malaria was highest among children between < 5
years of age (37 of 187 cases, 19.8%) and lowest among adults
age ³ 15 years of age (11 of 562 cases, 2.0%) (Table 2).
The age-related rate of severe malaria was highest in chil-
dren < 5 years of age (IRR = 10.1, 95% confidence interval
FIGURE 2. The age-related incident rate ratio of severeas comparedwith uncomplicatedmalaria (blue squares) in relation to individuals³15years
of age demonstrates peak incidence rate in children 2–4 years of age. The elevated rate of severemalaria persists until 11 years of age, after which it
is similar to individuals ³ 15 years of age. This figure appears in color at www.ajtmh.org.
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[CI] = 5.26–19.4, P < 0.001) but remained elevated in children
aged 5–15 years (IRR = 3.20, 95% CI = 1.68–6.11, P < 0.001)
compared with those ³ 15 years of age. When we subdivided
the agegroups further,we found that the rate of severemalaria
was highest in children aged 2–3 years (IRR = 14.8, 95% CI =
7.02–31.1, P < 0.001) (Figure 2). After age 11, the relative rate
of severemalaria was similar to that of those ³ 15 years of age.
To examine the association between older age and severe
malaria, we subdivided those individuals ³ 15 years of age into
two categories: 1) 15–49 years, who served as the reference
group and 2) ³ 50 years of age. The relative rate of severe
malaria was significantly higher in the older age group (IRR =
7.56, 95%CI = 2.36–24.2, P = 0.001), which was similar to the
rate observed in children 5–15 years of age (P = 0.60).
Among the 12 villages with at least three cases of severe
malaria, we identified two villages with different relative rates
of severe malaria when compared with Bugoye village, where
the health center is located. In Izinga, a low-lying village im-
mediately to the East, the relative rate of severe malaria was
significantly lower (adjusted IRR [aIRR] = 0.42, 95% CI =
0.18–1.00, P = 0.05). In contrast, there was a trend toward a
higher relative rate in the village of Ihani (aIRR= 2.51, 95%CI =
0.79–7.9,P= 0.12), which sits on a hillside approximately 1 km
from the health center (Figure 3). The mean age of individu-
als with confirmed parasitemia in Ihani was 24.6 years
(16.8–32.5), whereas in Izinga, it was 12.2 years (95% CI =
10.6–13.8, P < 0.001), suggesting more intense transmission
intensity in Izinga.
When the villages were stratified into quartiles of elevation,
we observed another trend toward a higher relative rate of
severe malaria among individuals from the highest elevation
villages (N = 18, aIRR = 1.82, 95% CI = 0.96–3.44, P = 0.07).
We could not detect a significant difference in the age of se-
vere malaria cases between villages of high and low elevation
(median age 8.5 versus 5.5 years, P = 0.40).
The most common clinical manifestation of severe malaria
was shock (systolic blood pressure < 70 mm Hg), which was
present in 22.2% (20 of 90) of cases with similar frequency
FIGURE 3. Map of the Bugoye sub-county highlighting the villages with higher (Ihani) and lower (Izinga) relative risk of severe malaria, compared
with Bugoye village, where the health center is located. This figure appears in color at www.ajtmh.org.
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between age groups. Seizures were reported in 11.5% (11 of
96) cases, most of who were < 5 years of age (P = 0.051),
whereas impaired consciousness defined as a Blantyre Coma
Score < 3 or GlascowComa Score < 11 was only noted in one
5-year-oldchildand twoelderlyadults. In the logistic regression
analysis, few demographic, seasonal, or clinical factors were
predictive of severe malaria (Table 3).
Of the laboratory criteria defining severe malaria, lactic ac-
idosis (19 of 96 cases, 19.8%) and hyperparasitemia (19 of
96 cases, 19.8%) were the most frequently identified. The
TABLE 3
Age-stratified multivariable regression analysis of correlates of severe malaria
Age < 5 years Age 5–15 years
aIRR 95% CI P value aIRR 95% CI P value
Female sex 1.37 0.61–3.08 0.45 0.71 0.35–1.44 0.34
Dry season 0.85 0.41–1.79 0.67 0.97 0.81–1.17 0.78
Symptoms
Cough 0.85 0.40–1.79 0.66 1.42 0.71–2.84 0.32
Diarrhea 1.06 0.47–2.40 0.89 0.88 0.27–2.91 0.84
Rhinorrhea 0.31 0.08–1.23 0.10 1.11 0.48–2.60 0.81
Vital signs
Febrile 1.26 0.62–2.57 0.53 0.74 0.33–1.64 0.45
Tachycardic 1.05 0.46–2.37 0.91 1.19 0.59–2.41 0.63
Hypoxia 4.36 2.26–8.42 < 0.001 3.39 1.52–7.60 0.003
Parasitemia
1–2,499 REF
2,500–9,999 1.29 0.34–4.93 0.71 1.04 0.34–3.11 0.95
10,000–99,999 1.75 0.61–5.02 0.30 1.78 0.66–4.78 0.26
100,000–249,999 1.50 0.44–5.11 0.52 2.05 0.47–8.89 0.34
aIRR = adjusted incidence rate ratio; CI = confidence interval. Bold values represent criteria for severe malaria.
FIGURE 4. Box plots showing log-transformed parasite densities (A), hemoglobin levels (B), venous lactate (C), and serumbicarbonate levels (D),
among those with uncomplicated and severemalaria stratified by age category. The dashed red line represents the respective threshold for severe
malaria for each measure. This figure appears in color at www.ajtmh.org.
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prevalence of lactic acidosis was similar across the three age
strata. Higher lactate levels were associated with increasing
parasite density (β = 0.1mmol/L per log parasite density, 95%
CI = 0.8–0.13, P < 0.001), and lactate levels were significantly
higher among patients with severe malaria than those with
uncomplicated malaria (3.24 versus 1.84 mmol/L, P < 0.001)
(Figure 4C).
Across all age groups, patients with severe malaria had
significantly higher parasite densities than those with un-
complicated malaria, and among those with severe malaria,
the level of parasitemia was significantly higher among
younger children (Figure 1A). Hyperparasitemia (³ 250,000
parasites/μL) was observed only in children < 15 years of age.
In the logistic regression analysis, higher parasite densities
were not associatedwith higher rates of severemalaria among
children, most notably among those < 5 years of age (Table 3).
Mean hemoglobin levels were lower among participants
with severe malaria compared with uncomplicated malaria,
yet when controlling for age, there was no significant differ-
ence in the hemoglobin level between those with severe and
uncomplicated malaria (Figure 3B). Instead, there was a gen-
eral trend toward lower hemoglobin levels in younger children.
Severe malaria anemia (Hb < 5.0 g/dL), however, was an in-
frequent complication, being found in only 3.3% of severe
cases (Table 3).
Of the individuals meeting the criteria for severe malaria,
only one child, who presented with severe anemia, was re-
ferred from the outpatient clinic to the district hospital. The
overall rate of admission to the health center inpatient ward for
patients meeting the criteria for severe malaria was 44.3%
(39 of 88), with rates ranging from 63.3% (19 of 30) for chil-
dren < 5 years of age to 18.2% (2 of 11) for individuals ³ 15
years of age. In comparison, the rate of admission for patients
with uncomplicated malaria was 14.0% (274 of 1,956).
Whereas discharge disposition was not recorded in individu-
als with a negative RDT, the rate of admission was non-
significantly higher among those with a positive RDT and
positive confirmatory microscopy than those with a positive
RDT, but negativemicroscopy (18.3% versus 9.8%,P = 0.22).
No inpatient deaths were reported during the study period.
Among the six cases of severe malaria in individuals ³ 50
years of age, the geometric mean parasite density was 23,389
parasites/μL compared with 1,916 parasites/μL in those of
similar age with uncomplicated malaria (P = 0.008). The mean
lactic acid level was also significantly higher in those whomet
the criteria for severe malaria (3.77 versus 1.73 mmol/L,
P < 0.001). Manifestations of severe malaria were three cases
of kidney injury including one casewith concurrent pulmonary
edema and impaired consciousness, one case of impaired
consciousness with a parasite density > 100,000 parasites/
μL, one case of lactic acidosis with a parasite density of
> 40,000 parasites/μL, and one case of shock accompanied
by a parasite density of > 40,000 parasites/μL.
DISCUSSION
In this prospective cohort of individuals seeking care at a
peripheral health center in ruralWesternUganda, we found that
FIGURE 5. Prevalence of clinical findings among patients with severe malaria as reported in recent studies in the sub-Saharan African Region.
This figure appears in color at www.ajtmh.org.
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severe anemia was an uncommon manifestation of severe
malaria. Although young children had lower hemoglobin levels
than adolescents and adults, we found no differences within
age groups between those who did and did not meet the cri-
teria for severe malaria. These results are in contrast to re-
ports from other regions of intense malaria transmission,
which historically are drawn from large referral centers
(Figure 5).8,23–25 Instead, shock and lactic acidosis were the
most common complications, each present in approximately
20% of cases. These findings suggest that the clinical char-
acteristics of severe malaria presenting to rural, peripheral
health centers may be different than previously observed in
referral centers, and therefore merit additional investigation of
the optimal methods for identification and management of
severe malaria in rural health centers in the region.26,27
There are a number of potential explanations for the low
prevalence of severe anemia in our cohort. First, given that the
general population prevalence of anemia in Uganda has de-
clined precipitously over the last decade,9 it is possible that
this finding reflects wide-scale improvements in childhood
nutrition and the management of soil-transmitted helminthi-
ases.28 Second, as first-line artemisinin combination thera-
pies have become increasingly available, there is more rapid
clearing of parasitemia and less treatment failure.29,30 Lastly,
the epidemiology of severe malaria at peripheral facilities may
be different than that observed in hospital-based populations,
where most of the prior studies about the classification of
severe malaria were conducted. This difference could be
explained by the referral to higher level facilities and/or
bypassing of peripheral health among the most severe cases.
Although no inpatient deaths were recorded during the study
period, the primary objective of the study was to assess the
accuracy of an RDT, and we did not follow patients beyond the
initial disposition decision made in the outpatient clinic. It is
possible that we underestimated mortality in the event that 1)
deaths were not accurately recorded in inpatient registers or 2)
deaths occurred after transfer to a higher level facility or post-
discharge fromtheoutpatient clinic or inpatientward, outcomes
ofwhichare typically not provided to the referringcenter. Similar
trends have been demonstrated elsewhere, albeit in referral
hospitals, where it was found that a significant proportion of
deaths and adverse events occurred after discharge.31,32
The incidence rate of severe malaria in our cohort peaked
between 2 and 3 years of age, a finding that is consistent with
the moderate-to-high intensity of transmission.33 Yet an ele-
vated risk of severe malaria persisted throughout the first
decade of life, with nearly a quarter of cases (21 of 96, 21.9%)
occurring in individuals older than 10 years of age. We also
identified a second period of risk among adults ³ 50 years of
age, which was similar in magnitude to that seen in children
5–15 years of age (P = 0.60). This finding suggests the pos-
sibility of an age-related decline in functional immunity similar
to other infectious diseases, which could have a significant
public health impact as life expectancy increases in malaria
endemic countries.
To our knowledge, this study represents the first in-
vestigation of severe malaria in sub-Saharan Africa using
widely accepted, objective clinical and laboratory criteria
conducted outside of district hospitals or academic referral
centers. The study also has a number of limitations. First, the
studywasconductedat a single site over a relatively short time
period, and the number of severe cases was relatively small,
despite the large number of individuals screened. Second, the
rate of study nonparticipation was relatively high, especially
amongyoungchildren.Wehypothesize that parentsmayhave
declined study-related testing, which entailed another blood
draw and a longer wait, once the RDT results were known.
However, as previously reported, we found little evidence in
differences in clinical status or disposition between thosewho
did and did not participate, partially mitigating this concern.34
Third, our study design did not incorporate a control group
comprised of RDT negative individuals. Therefore, it is pos-
sible that we have attributed manifestations of severe malaria
to P. falciparum parasitemia when in fact individuals had al-
ternative causes of illness in the setting of asymptomatic
parasitemia. Lastly, study staff, who were responsible for re-
cording the clinical histories and vital signs used to define
severe malaria, were nonprofessional health-care workers.
Before study implementation, we conducted 3 days of di-
dactic and practical training with the staff, who were then
supervised by the site director, a senior clinical officer. In
addition, we attempted to minimize the potential for mea-
surement bias by using automated equipment, including
thermometers, blood pressure cuffs, and pulse oximeters.
CONCLUSIONS
At a peripheral health center in rural Uganda, severe anemia
was an uncommon complication of severe malaria. Instead,
shock and lactic acidosis were the most common findings,
each encountered in approximately 20% of cases. These re-
sults merit further investigation, with a renewed focus on the
optimal identification and triage of severe malaria in rural
health centers, particularly because adverse outcomes as-
sociated with lactic acidosis is high.
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